Skip to main content
logo
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
13.15
-0.33 (-2.45%)
Apr 2, 2026, 4:00 PM EDT - Market closed

Entrada Therapeutics Revenue

In the year 2025, Entrada Therapeutics had annual revenue of $25.42M, down -87.94%. Entrada Therapeutics had revenue of $1.30M in the quarter ending December 31, 2025, a decrease of -96.53%.

Revenue (ttm)
$25.42M
Revenue Growth
-87.94%
P/S Ratio
18.62
Revenue / Employee
$167,243
Employees
152
Market Cap
473.40M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202525.42M-185.36M-87.94%
Dec 31, 2024210.78M81.77M63.38%
Dec 31, 2023129.01M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
4D Molecular Therapeutics85.21M
ADC Therapeutics81.36M
Fulcrum Therapeutics80.00M
Assembly Biosciences72.30M
Verastem30.91M
Upstream Bio2.85M
Absci2.80M
Lyell Immunopharma36.00K
Revenue Rankings

TRDA News

More News